Global Coronary Artery Disease Market Share 2024, Forecast To 2033

8 Mar, 2024

The coronary artery disease market has witnessed rapid growth, escalating from $26.3 billion in 2023 to $28.97 billion in 2024, with a remarkable compound annual growth rate (CAGR) of 10.2%. This surge can be attributed to several factors including the prevalence of coronary artery disease and advancements in minimally invasive surgeries and pharmacological treatments. Looking ahead, the market is poised for continued rapid expansion, with projections indicating a market size of $42.65 billion by 2028, growing at a CAGR of 10.2%. This anticipated growth is fueled by factors such as lifestyle changes, an increasing focus on telemedicine and remote monitoring, and the development of novel drug therapies. Major trends in the forecast period include the emergence of gene therapies, the integration of artificial intelligence in diagnosis, and a heightened focus on mental health in coronary artery disease care, alongside the rise of home-based healthcare services and remote cardiac rehabilitation programs.

Global Coronary Artery Disease Market Key Driver

The rise in the prevalence of coronary artery disease, evidenced by statistics on coronary heart disease-related deaths and affected individuals, is expected to drive growth in the coronary artery disease market. As coronary artery disease affects millions globally and remains a leading cause of mortality, the demand for treatments and interventions to manage the condition is expected to rise. With approximately 5% of adults affected by coronary artery disease, the market for coronary artery disease treatments is poised for substantial expansion to meet healthcare needs.

Get A Free Sample Of The Global Coronary Artery Disease Market Report

Global Coronary Artery Disease Market Segments

The coronary artery disease market covered in this report is segmented –
1) Treatment:Medication, Surgery, Additional Therapy, Other Treatments
2) Diagnosis:Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis
3) Distribution Channel:Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels
4) End-User:Hospitals, Specialty Clinics, Other End-Users
By Geography: The countries covered in the coronary artery disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. North America was the largest region in the coronary artery disease market in 2023. The regions covered in the coronary artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Major Coronary Artery Disease Industry Players

Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca plc; Abbott Laboratories; GlaxoSmithKline plc; Gilead Sciences Inc.; Amgen Inc. ; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Aurobindo Pharma Ltd.; Hikma Pharmaceuticals plc; Amneal Pharmaceuticals Inc.; Chiesi Farmaceutici S.p.A.; Lupin Pharmaceuticals Inc.; Wockhardt Ltd.; Honya Medical Inc.; Idorsia Pharmaceuticals Ltd.; Cytokinetics Inc.; Kowa Pharmaceuticals America Inc.; Sinotau Pharmaceutical Group; HRV Global Life Sciences; Barr Pharmaceuticals Inc.; AdvanceCor GmbH; Deutsches Zentrum für Herz- Kreislauf-Forschung (DZHK) e.V.

Get The Full Global Coronary Artery Disease Market Report

Coronary Artery Disease Market Overview

Coronary artery disease (CAD) is a medical condition that affects the coronary arteries, the blood vessels that supply oxygen-rich blood to the heart muscle. Coronary artery disease occurs when arteries become narrowed or blocked due to plaque buildup, a substance composed of cholesterol, fat, calcium, and other substances.